US Stock MarketDetailed Quotes
GUTS Fractyl Health
- 7.150
- +0.530+8.01%
Close May 15 16:00 ET
342.46MMarket Cap3.25P/E (TTM)
7.170High6.490Low197.45KVolume6.640Open6.620Pre Close1.37MTurnover2.69%Turnover RatioLossP/E (Static)47.90MShares14.50052wk High4.07P/B52.43MFloat Cap5.75052wk Low--Dividend TTM7.33MShs Float14.500Historical High--Div YieldTTM10.27%Amplitude5.750Historical Low6.925Avg Price1Lot Size
About Fractyl Health Company
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
Company Profile
SymbolGUTS
Company NameFractyl Health
Listing DateFeb 2, 2024
Issue Price15.00
CEODr. Harith Rajagopalan, M.D.,PhD
MarketNASDAQ
Employees102
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3 Van de Graaff Drive,Suite 200
CityBurlington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01803
Phone1-781-902-8800
Websitehttp://www.fractyl.com
Company Executives
- Name
- Position
- Salary
- Dr. Harith Rajagopalan, M.D.,PhD
- Chief Executive Officer and Director
- 3.56M
- Jay D. Caplan
- President and Chief Product Officer
- 2.87M
- Dr. Timothy Kieffer, PhD
- Chief Scientific Officer
- 3.46M
- Lisa A. Davidson
- Chief Financial Officer, Treasurer and Principal Accounting Officer
- --
- Allan R. Will
- Chairman of the Board
- 2.41M
- Dr. Clive A. Meanwell, M.D.,PhD
- Independent Director
- --
- Kelly Ann Barnes
- Independent Director
- 43.60K
- Amy W. Schulman
- Independent Director
- 43.60K
- Samuel Conaway
- Independent Director
- --
- Ajay Royan
- Independent Director
- --
- Senator William W. Bradley
- Independent Director
- 43.60K
- Marc Elia
- Independent Director
- --
- Sarah Toomey
- General Counsel and Corporate Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
